Avingtrans Plc’s Brisbane Magnetica Ltd Appoints US Distributor

Avingtrans plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its subsidiary, Magnetica Limited, has signed a new strategic partnership with Televere Systems, LLC, a leader in radiography product distribution. This agreement appoints Televere as the official US distributor for Magnetica’s products.

Commencing immediately, this partnership was officially unveiled at the RSNA (Radiological Society of North America) 2023 annual event in Chicago. It marks a significant achievement in Magnetica’s expansion strategy, reinforcing its commitment to providing advanced MRI solutions to the U.S. market. Magnetica is developing state-of-the-art technology using ultra-compact superconducting magnets in an MRI technology that will operate without liquid helium. Magnetica plans to seek FDA clearance for the product by mid-2024.

RSNA proved an ideal platform for Adaptix and Magnetica to collaboratively showcase their innovations for the first time. The exhibition proved to be a notable success for both companies, as attendees witnessed an array of innovation from these emerging players in the medical imaging market. Adaptix presented its 3D x-ray Ortho system in the US after having received its FDA 510k clearance earlier in the year. The 3D imaging system, designed for point-of-care and offering low-dose 3D diagnostic imaging of extremities, garnered enthusiastic praise from potential customers and distributors alike.

Duncan Stovell, CEO of Magnetica, commented:

“We’re excited about the potential our Helium-free MRI technology holds and confident that in Televere, we have chosen the perfect partner to bring it to the US market. Televere is a dynamic, innovative and customer-focused organisation with a strong track record of success. This new partnership will support both companies’ growth strategies by enabling easier access to state-of-the-art MRI technology.

Randy Quaal, General Manager of Televere, commented:

“With a dynamic team of over 40 professionals, our team is well positioned to represent Magnetica’s products effectively and our alliance with Magnetica is a significant step forward. The versatility of Magnetica’s products aligns perfectly with our mission to meet and exceed customer expectations in the radiography field and we’re looking forward to bringing this innovative new technology to our US customer base.”

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Magnetica Ltd – Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica’s structure now includes two other business units: 

Scientific Magnetics – Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

Tecmag Inc – Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Avingtrans plc's Adaptix, an innovator in 3D X-Ray imaging, wins Aerospace Technology Innovation Award for its breakthrough in non-destructive testing.
    Avingtrans plc CEO Steve McQuillan discusses preliminary results for the year ended 31 May 2024, highlighting record sales, strategic acquisitions, and future growth.
    Avingtrans PLC (LON:AVG) announces a remarkable 17.3% revenue increase to £136.6m for the year ended 31 May 2024, highlighting strategic investments and robust growth across energy and medical sectors.
    Avingtrans PLC (LON:AVG) reports record revenue and adjusted EBITDA ahead of expectations for the financial year ending 31 May 2024, with strong growth across its divisions.
    Avingtrans plc CEO Steve McQuillan discusses interim results, acquisitions, and company restructuring in an exclusive interview with DirectorsTalk.
    Avingtrans PLC (LON:AVG) announces interim results for Nov 2023, showing a 30.4% revenue increase and 14.1% rise in adjusted EBITDA. Operating highlights include acquisitions and new contracts in various sectors.

      Search

      Search